True Nature|Mitesco (TNTY). Coverage Report Issued.

Record Volume and Gradually Rising Price Portends to Higher Prices in 2020 as True Nature Executes on Recently Announced Incubator Strategy.
Biotech Stock Review,

Premier Health (PHGRF) Announces Definitive Agreement to Acquire Livecare.

Livecare is an established leader in the Canadian digital health spaceHave provided over 27,000 telemedicine visitsService over 500 independent active health practitioner...
biotech stock review

7 Million Telehealth Users This Year, Expected to Drive Revenues to $36 Billion in...

As boomers age, experts predict the telehealth market will grow from a $14.3 billion industry in 2013 to a $36.2 billion...

Mass General Brigham to Invest $100 Million in Telehealth and Digital Tools.

The five-year project aims to support consumer-centered care and patient engagement technology use. PatientEngagementHIT.com "Project...
Internet Stock Review

New Preferred Stock IPOs, October 2019

Article ArchivePreferred Stock Investing Website Summary Thirteen new preferred stocks were introduced during October offering...
True Nature, Mitesco, Biotech Stock Review

Is True Nature (TNTY) $0.04, Nearing a Breakout?

After a Tough Year, a Series of Development Releases Appears to Have Halted True Natures Downtrend and Move to a Possible...
True Nature, Mitesco, Biotech Stock Review

True Nature’s (TNTY) CEO Larry Diamond on Wall Street Analyzer.

Larry Diamond Reveals Some of True Nature's Goals and Ambitions to Incubate Medical Related Startups to Benefit All Shareholders.
True Nature, Biotech Stock Review

True Nature | Mitesco (TNTY), Perking Up.

Is it too early to nick-name True Nature's Medtech incubator Mitesco the "Mighty Mitesco?" Of course it's too early - but it...

Remember This? Alta Vista Cancels IPO. David Wetherell Takes a $2 Billion Beating.

We are going through some of our very old 'incubator files' back from when we ran the Incubator Stock Review, a spinoff...

IDEALAB. First Mover, Last Survivor.

CLICK TO READ Founded by Bill Gross in 1996, Idealab has created more than 150 companies, which fueled...

Latest article

Immunomedics, Biotech Stock Review

Biotech 5 Pack. 5 Biotech Stocks We Expect to Double in 2020.

Our First Newsletter of 2020, We Come out Swinging! Yes, you read it right. Five of our favorite...
Citius Pharmaceutical, CTXR, Biotech Stock Review

Citius Pharma (CTXR) Now Our #1 Ranked Idea for 2020.

Citius Pharmaceuticals (CTXR) is hands down one of the most exciting long-term opportunities we have come across since we first launched the...
Oramed, Biotech Stock REview

Oramed (ORMP) $5.24, Focused on Pill Form Insulin. Is China First?

New technology could revolutionize market of 500 million diabetes patients (i24 News).